HIV Vacuolar Myelopathy — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — HIV-associated vacuolar myelopathy — a diagnosis of exclusion; caused by HIV-mediated damage to posterior and lateral columns of the spinal cord; no specific treatment beyond ART optimisation
HIV-associated vacuolar myelopathy (HIVM) is a progressive myelopathy affecting the posterior and lateral columns (resembling subacute combined degeneration of B12 deficiency). It is a diagnosis of exclusion — all treatable causes must be ruled out (HTLV-1, syphilis, VZV, B12/copper deficiency, cord compression, NMOSD). HIVM can occur even with suppressed VL, reflecting prior or ongoing low-level HIV-mediated CNS damage. There is no specific treatment beyond ART optimisation. Symptomatic management: spasticity treatment (Baclofen), bladder management, physiotherapy.
Reference: BHIVA 2022 – Neurological complications; NICE 2024